7YG5 image
Deposition Date 2022-07-11
Release Date 2023-11-29
Last Version Date 2024-11-13
Entry Detail
PDB ID:
7YG5
Title:
Structure of human R-type voltage-gated CaV2.3-alpha2/delta1-beta1 channel complex in the topiramate-bound state
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.00 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent R-type calcium channel subunit alpha-1E
Gene (Uniprot):CACNA1E
Chain IDs:A
Chain Length:2313
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent L-type calcium channel subunit beta-1
Gene (Uniprot):CACNB1
Chain IDs:B
Chain Length:598
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Voltage-dependent calcium channel subunit alpha-2/delta-1
Gene (Uniprot):CACNA2D1
Chain IDs:C (auth: D)
Chain Length:1103
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structural insights into the allosteric effects of the antiepileptic drug topiramate on the Ca V 2.3 channel.
Biochem.Biophys.Res.Commun. 725 150271 150271 (2024)
PMID: 38901222 DOI: 10.1016/j.bbrc.2024.150271

Abstact

The R-type voltage-gated calcium channel CaV2.3 is predominantly located in the presynapse and is implicated in distinct types of epileptic seizures. It has consequently emerged as a molecular target in seizure treatment. Here, we determined the cryo-EM structure of the CaV2.3-α2δ1-β1 complex in the topiramate-bound state at a 3.0 Å resolution. We provide a snapshot of the binding site of topiramate, a widely prescribed antiepileptic drug, on a voltage-gated ion channel. The binding site is located at an intracellular juxtamembrane hydrophilic cavity. Further structural analysis revealed that topiramate may allosterically facilitate channel inactivation. These findings provide fundamental insights into the mechanism underlying the inhibitory effect of topiramate on CaV and NaV channels, elucidating a previously unseen modulator binding site and thus pointing toward a route for the development of new drugs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures